I'm not a hard TA guy, but even to the casual eye there appears to be a break of trend taking place to the upside here. Obviously there was consistent selling pressure all through 2012 by Morgans and other instos, likely due to their internal trading guidlines re. not being able to withstand any exposure to the element of sovereign risk. However, should it be the case that for ROL the S.R. is in fact a non-issue, then by all other measures this stock has been oversold to buggery. If the insto selling pressure is now finally over, then we can expect a steady recovery. Obviously it's not been a good past 12 months for holders, but it seems to be showing signs of the weather clearing; the breaking of downtrend on lowish volume could be indicative of this. If this is the case, it wouldn't take much for it to run hard from here on positive news, which seems to be on the cards with the program of assay releases around the corner.
I tend to feel that POST #8902020 by Discocopper, as well as POST #8404603 by John435(who's posts I always lend weight to) are compelling.
In combination with the fact that the MC is presently dominated by the company's solid cash position, and the additional element of the endorsment by a local Indonesian heavyweight investor, I feel this story is more Bullish than bearish at the moment. I took a position today, both for the ST anticipation of further good assays, and the possibility that ROL might be on the cusp of a mid-term technical recovery. The next eight weeks should reveal whether the uptrend is legitimately in place...but the signs are there...
ROL Price at posting:
41.5¢ Sentiment: ST Buy Disclosure: Held